GSK profit rises to £5.7bn as speciality medicines drive growth
GSK reports a net profit of £5.7 billion, a sharp rise driven by strong sales in HIV, respiratory, and cancer drugs, recovering from Zantac lawsuits.
Read More: https://punchng.com/gsk-profit-rises-to-5-7bn-as-speciality-medicines-drive-growth/